402
Views
16
CrossRef citations to date
0
Altmetric
Review

Non-adherence with bisphosphonates among patients with osteoporosis: impact on fracture risk and healthcare cost‏

, &
Pages 359-370 | Received 25 Jan 2016, Accepted 23 Mar 2016, Published online: 12 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Adrian Wagg. (2016) Persistence with medication and overactive bladder: an ongoing challenge. Expert Review of Pharmacoeconomics & Outcomes Research 16:4, pages 475-481.
Read now

Articles from other publishers (15)

Enrique Casado, José Rosas, Carlos Rubio-Terrés, Darío Rubio-Rodríguez, Mitra Boolell & Ignacio Arístegui. (2023) Cost–effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain. Journal of Comparative Effectiveness Research 12:11.
Crossref
Vaiva Gerasimaviciute, Rohini Mathur, Kathryn Elizabeth Mansfield, Matthew Paul McDermott, David Edward Neasham & James Liam O'Kelly. (2023) Osteoporosis-related characteristics in care home residents in England: a retrospective cohort study. BJGP Open 7:2, pages BJGPO.2022.0142.
Crossref
Li Feng Tan, Sim Meng Ying, Jeremy Teng, Arthi Premkumar, Andre Teck Huat Tan & Santhosh Seetharaman. (2022) The Impact of Frailty, Falls and Cognition on Osteoporosis Management in the Oldest Old. Calcified Tissue International 111:2, pages 145-151.
Crossref
Diane Kleinermans, Andrew Joyson & Heather Wray. (2022) An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate. Pharmacology Research & Perspectives 10:3.
Crossref
Michael J. Miller, Tzuchen Jou, Maria I. Danila, Amy S. Mudano, Elizabeth J. Rahn, Ryan C. Outman & Kenneth G. Saag. (2021) Use of path modeling to inform a clinical decision support application to encourage osteoporosis medication use. Research in Social and Administrative Pharmacy 17:7, pages 1267-1275.
Crossref
Ayano Kelly, Kathleen Tymms, Maarten Wit, Susan J. Bartlett, Marita Cross, Therese Dawson, Mary De Vera, Vicki Evans, Michael Gill, Geraldine Hassett, Irwin Lim, Karine Manera, Gabor Major, Lyn March, Sean O’Neill, Marieke Scholte-Voshaar, Premarani Sinnathurai, Daniel Sumpton, Armando Teixeira‐Pinto, Peter Tugwell, Bart Bemt & Allison Tong. (2020) Patient and Caregiver Priorities for Medication Adherence in Gout, Osteoporosis, and Rheumatoid Arthritis: Nominal Group Technique. Arthritis Care & Research 72:10, pages 1410-1419.
Crossref
J. Morley, A. Moayyeri, L. Ali, A. Taylor, M. Feudjo-Tepie, L. Hamilton & J. Bayly. (2019) Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink. Osteoporosis International 31:3, pages 533-545.
Crossref
Satoshi Soen, Hideaki Kishimoto, Hiroshi Hagino, Teruki Sone, Hiroaki Ohishi, Tsukasa Fujimoto, Emma Sasaki, Sakae Tanaka & Toshitsugu Sugimoto. (2019) Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis. Journal of Bone and Mineral Metabolism 38:1, pages 86-98.
Crossref
Patrice Fardellone, Stefano Lello, Antonio Cano, Eloisa de Sá Moreira, Renato Watanabe de Oliveira, Guilherme Silva Julian & Boxiong Tang. (2019) Real-world Adherence and Persistence with Bisphosphonate Therapy in Postmenopausal Women: A Systematic Review. Clinical Therapeutics 41:8, pages 1576-1588.
Crossref
Jian Mo, Kangmao Huang, Xumeng Wang, Xinyu Sheng, Qiang Wang, Xiangqian Fang & Shunwu Fan. (2018) The Sensitivity of Orthopaedic Surgeons to the Secondary Prevention of Fragility Fractures. Journal of Bone and Joint Surgery 100:24, pages e153.
Crossref
J. Liu, H. Guo, P. Rai, L. Pinto & R. Barron. (2018) Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis. Osteoporosis International 29:11, pages 2409-2417.
Crossref
José Luis IparraguirreJosé Luis Iparraguirre. 2018. Economics and Ageing. Economics and Ageing 81 145 .
Hajime Orimo, Masayo Sato, Shuichi Kimura, Keiko Wada, Xuelu Chen, Shigeto Yoshida & Bruce Crawford. (2017) Understanding the factors associated with initiation and adherence of osteoporosis medication in Japan: An analysis of patient perceptions. Osteoporosis and Sarcopenia 3:4, pages 174-184.
Crossref
Varda Shalev, Sarah Sharman Moser, Inbal Goldshtein, Jingbo Yu, Clara Weil, Sophia Ish-Shalom, Vanessa Rouach & Gabriel Chodick. (2017) Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data. Annals of Pharmacotherapy 51:9, pages 757-767.
Crossref
Michael R. McClung. (2017) Denosumab for the treatment of osteoporosis. Osteoporosis and Sarcopenia 3:1, pages 8-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.